Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation

Transplantation Society International CMV Consensus Group

Research output: Contribution to journalArticle

493 Citations (Scopus)

Abstract

Cytomegalovirus (CMV) continues to be one of the most common infections after solid-organ transplantation, resulting in significant morbidity, graft loss, and adverse outcomes. Management of CMV varies considerably among transplant centers but has been become more standardized by publication of consensus guidelines by the Infectious Diseases Section of The Transplantation Society. An international panel of experts was reconvened in October 2012 to revise and expand evidence and expert opinion-based consensus guidelines on CMV management, including diagnostics, immunology, prevention, treatment, drug resistance, and pediatric issues. The following report summarizes the recommendations.

Original languageEnglish (US)
Pages (from-to)333-360
Number of pages28
JournalTransplantation
Volume96
Issue number4
DOIs
StatePublished - Aug 27 2013
Externally publishedYes

Fingerprint

Organ Transplantation
Cytomegalovirus
Guidelines
Transplants
Expert Testimony
Allergy and Immunology
Drug Resistance
Communicable Diseases
Publications
Pediatrics
Morbidity
Infection

Keywords

  • CMV
  • Cytomegalovirus
  • Ganciclovir
  • Prevention
  • Prophylaxis
  • Resistance
  • Treatment
  • Valganciclovir

ASJC Scopus subject areas

  • Transplantation

Cite this

Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. / Transplantation Society International CMV Consensus Group.

In: Transplantation, Vol. 96, No. 4, 27.08.2013, p. 333-360.

Research output: Contribution to journalArticle

Transplantation Society International CMV Consensus Group. / Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. In: Transplantation. 2013 ; Vol. 96, No. 4. pp. 333-360.
@article{f4f6e437fd6b46beb70faf5722522d71,
title = "Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation",
abstract = "Cytomegalovirus (CMV) continues to be one of the most common infections after solid-organ transplantation, resulting in significant morbidity, graft loss, and adverse outcomes. Management of CMV varies considerably among transplant centers but has been become more standardized by publication of consensus guidelines by the Infectious Diseases Section of The Transplantation Society. An international panel of experts was reconvened in October 2012 to revise and expand evidence and expert opinion-based consensus guidelines on CMV management, including diagnostics, immunology, prevention, treatment, drug resistance, and pediatric issues. The following report summarizes the recommendations.",
keywords = "CMV, Cytomegalovirus, Ganciclovir, Prevention, Prophylaxis, Resistance, Treatment, Valganciclovir",
author = "{Transplantation Society International CMV Consensus Group} and Kotton, {Camille N.} and Deepali Kumar and Caliendo, {Angela M.} and Anders {\AA}sberg and Sunwen Chou and Lara Danziger-Isakov and Atul Humar and I. Lautenschlager and J. Preiksaitis and D. Abate and V. Emery and R. Khanna and D. Lilleri and O. Manuel and M. Sester and E. Blumberg and Camargo, {L. F.} and C. Gordon and S. Huprikar and N. Kamar and R. Lattes and P. Merville and N. Mueller and G. Paget and T. Reischig and N. Singh and Snydman, {D. R.} and J. Torre-Cisneros and G. Westall and M. Zamora and J. Harrison and M. Morris and P. Munoz and W. Rawlinson and S. Alain and F. Baldanti and Limaye, {A. P.} and N. Lurain and U. Allen and M. Green and Herold, {B. C.} and M. Michaels",
year = "2013",
month = "8",
day = "27",
doi = "10.1097/TP.0b013e31829df29d",
language = "English (US)",
volume = "96",
pages = "333--360",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation

AU - Transplantation Society International CMV Consensus Group

AU - Kotton, Camille N.

AU - Kumar, Deepali

AU - Caliendo, Angela M.

AU - Åsberg, Anders

AU - Chou, Sunwen

AU - Danziger-Isakov, Lara

AU - Humar, Atul

AU - Lautenschlager, I.

AU - Preiksaitis, J.

AU - Abate, D.

AU - Emery, V.

AU - Khanna, R.

AU - Lilleri, D.

AU - Manuel, O.

AU - Sester, M.

AU - Blumberg, E.

AU - Camargo, L. F.

AU - Gordon, C.

AU - Huprikar, S.

AU - Kamar, N.

AU - Lattes, R.

AU - Merville, P.

AU - Mueller, N.

AU - Paget, G.

AU - Reischig, T.

AU - Singh, N.

AU - Snydman, D. R.

AU - Torre-Cisneros, J.

AU - Westall, G.

AU - Zamora, M.

AU - Harrison, J.

AU - Morris, M.

AU - Munoz, P.

AU - Rawlinson, W.

AU - Alain, S.

AU - Baldanti, F.

AU - Limaye, A. P.

AU - Lurain, N.

AU - Allen, U.

AU - Green, M.

AU - Herold, B. C.

AU - Michaels, M.

PY - 2013/8/27

Y1 - 2013/8/27

N2 - Cytomegalovirus (CMV) continues to be one of the most common infections after solid-organ transplantation, resulting in significant morbidity, graft loss, and adverse outcomes. Management of CMV varies considerably among transplant centers but has been become more standardized by publication of consensus guidelines by the Infectious Diseases Section of The Transplantation Society. An international panel of experts was reconvened in October 2012 to revise and expand evidence and expert opinion-based consensus guidelines on CMV management, including diagnostics, immunology, prevention, treatment, drug resistance, and pediatric issues. The following report summarizes the recommendations.

AB - Cytomegalovirus (CMV) continues to be one of the most common infections after solid-organ transplantation, resulting in significant morbidity, graft loss, and adverse outcomes. Management of CMV varies considerably among transplant centers but has been become more standardized by publication of consensus guidelines by the Infectious Diseases Section of The Transplantation Society. An international panel of experts was reconvened in October 2012 to revise and expand evidence and expert opinion-based consensus guidelines on CMV management, including diagnostics, immunology, prevention, treatment, drug resistance, and pediatric issues. The following report summarizes the recommendations.

KW - CMV

KW - Cytomegalovirus

KW - Ganciclovir

KW - Prevention

KW - Prophylaxis

KW - Resistance

KW - Treatment

KW - Valganciclovir

UR - http://www.scopus.com/inward/record.url?scp=84883455574&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883455574&partnerID=8YFLogxK

U2 - 10.1097/TP.0b013e31829df29d

DO - 10.1097/TP.0b013e31829df29d

M3 - Article

C2 - 23896556

AN - SCOPUS:84883455574

VL - 96

SP - 333

EP - 360

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 4

ER -